ArticleClinical and experimental nephrology2009
Renal cell carcinoma and arterial hypertension.
Article in Clinical and experimental nephrology, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers, 2 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
15 citing papers in PubMed, 2 syntheses or guidelines pooled it, 27 citations in OpenAlex.
- Prevalence and management of hypertension in childhood, adolescent, and young adult cancer survivors: a systematic review and meta-analysis.Hypertension research : official journal of the Japanese Society of Hypertension · 2025Pooled it
- Incidence and Risk of Hypertension in Cancer Patients Treated With Atezolizumab and Bevacizumab: A Systematic Review and Meta-Analysis.Frontiers in oncology · 2021Pooled it
- Association of cancer with the risk of developing hypertension.European heart journal. Quality of care & clinical outcomes · 2024Observational
- Transcription factor E3 renal cell carcinoma presenting as secondary hypertension.Current urology · 2023Article
- Stress Reactivity, Susceptibility to Hypertension, and Differential Expression of Genes in Hypertensive Compared to Normotensive Patients.International journal of molecular sciences · 2022Article
- Open kidney cancer surgery and perioperative cardiac arrhythmias.Central European journal of urology · 2020Article
- Hypertension in Cancer Patients and Survivors: Epidemiology, Diagnosis, and Management.JACC. CardioOncology · 2019Article
- Polycythemia with Renal Cell Carcinoma and Normal Erythropoietin Level.Case reports in urology · 2019Article
- Article
- Physical activity and sedentary behavior in relation to mortality among renal cell cancer survivors.PloS one · 2018Article
- Article
- Perioperative Considerations in Metastatic Renal Cell Carcinoma.Reviews in urology · 2016Article
- Evidence for aldosterone-dependent growth of renal cell carcinoma.International journal of experimental pathology · 2014Article
- Effects of partial nephrectomy on postoperative blood pressure.Korean journal of urology · 2012Article
- Hypertension and risk of renal cell carcinoma among white and black Americans.Epidemiology (Cambridge, Mass.) · 2011Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThe association between renal cell carcinoma and arterial hypertension has been the subject of various studies. These studies have not been consistent in clarifying the relationship between the two. Some authors contend that arterial hypertension is a consequence of renal cell carcinoma, which secretes vasoactive peptides. Others claim that arterial hypertension is a risk factor for the development of renal cell carcinoma. The purpose of our study is to assess if there is a direct connection between arterial hypertension and renal cell carcinoma.
methodsOut of 16,755 patients who were examined by ultrasonography, 40 were diagnosed with renal tumors. Of the 40 patients, 29 had malignant renal tumors, and 11 had benign renal tumors. These diagnoses were confirmed by CT scan, renal biopsy, and histology. Most of the patients with renal cell carcinoma (79.3%) had arterial hypertension. The group with benign renal tumors served as a control group. Out of the 29 patients with malignant renal cell carcinoma, 24 patients were treated with total nephrectomy, one had a partial nephrectomy, and four patients were too unwell for surgical intervention. In the group of those with benign renal tumors, seven patients had partial nephrectomies for the removal of angiomyolipomas. The personal histories were taken at the initiation of the study, and vital signs were obtained before and after surgery. Statistical analyses were performed using the Statistical Package for Social Sciences, version 10.0.
resultsIn the malignant group, the systolic blood pressure (SBP) before surgery was 157.41 +/- 27.86 mmHg, and the diastolic blood pressure (DBP) was 97.24 +/- 15.33 mmHg, while in the benign group, SBP was 134.55 +/- 17.53 mmHg, and DBP was 88.18 +/- 14.01 mmHg. In the malignant group in those who had undergone nephrectomies, the mean systolic pressure was 136.82, and the diastolic pressure was 85.90. In the benign group, the systolic and diastolic blood pressures were normal before and after surgery.
conclusionIn the group of patients with both renal cell carcinoma and arterial hypertension, their hypertension was resolved after they underwent nephrectomies. In conclusion, our data suggest that renal cell carcinomas may cause arterial hypertension.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.